Physician profile
Collin D Cooper
NPI 1982986238
$11,373.91
in general payments reported to CMS, 2019-2025
42 companies · $4,419 in 2025
The $4,419 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,028 · 2022: $1,443 · 2023: $2,226 · 2024: $2,258 · 2025: $4,419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,606 · Consulting Fee: $1,000 · Travel and Lodging: $289 · Education: $8.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,605.71 |
| Consulting Fee | $1,000.00 |
| Travel and Lodging | $288.72 |
| Education | $8.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $4,025.80 | 2021-2025 | Erleada, Rybrevant, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $1,268.94 | 2021-2025 | |
| Astellas Pharma US INC | $1,025.03 | 2021-2025 | Xtandi, Myrbetriq, Veozah |
| Sumitomo Pharma America, INC. | $641.34 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $600.23 | 2021-2025 | |
| Dendreon Pharmaceuticals LLC | $505.98 | 2021-2023 | Provenge |
| Abbvie INC. | $260.49 | 2022-2025 | |
| Medtronic, INC. | $242.21 | 2021-2025 | Interstim |
| Urovant Sciences INC | $204.92 | 2021-2022 | |
| Myovant Sciences INC. | $177.11 | 2021-2022 | |
| Endo USA, INC. | $171.57 | 2024-2025 | Xiaflex |
| Boston Scientific Corporation | $171.15 | 2021-2023 | Lithovue |
| Urogen Pharma, INC. | $169.56 | 2021-2025 | Jelmyto |
| Janssen Scientific Affairs, LLC | $165.53 | 2025 | Erleada |
| Procept Biorobotics Corporation | $148.33 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $143.10 | 2022-2025 | |
| Coloplast Corp | $127.66 | 2023-2025 | Speedicath |
| Merck Sharp & Dohme LLC | $111.82 | 2021-2023 | Lynparza, Keytruda |
| Tolmar Pharmaceuticals, INC. | $111.65 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $110.07 | 2021-2023 | Lynparza |
| Tolmar, INC. | $104.54 | 2023-2024 | |
| Teleflex LLC | $101.08 | 2021-2025 | Urolift |
| Civco Medical Instruments | $74.27 | 2025 | |
| Immunitybio, INC. | $69.91 | 2024-2025 | |
| Telix Pharmaceuticals | $58.43 | 2023-2024 | Illuccix |
| Novartis Pharmaceuticals Corporation | $58.18 | 2024-2025 | |
| Amgen INC. | $55.08 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $52.82 | 2023-2024 | Xiaflex |
| 180 Medical, INC. | $51.66 | 2021-2024 | |
| Ferring Pharmaceuticals INC. | $51.25 | 2025 | Adstiladrin |
| Dentsply Ih Ab | $40.13 | 2023 | Lofric |
| Bluewind Medical | $37.63 | 2024 | Revi |
| Mission Pharmacal Company | $36.57 | 2023-2024 | Uribel Tabs |
| Verity Pharmaceuticals INC. | $28.17 | 2025 | Tlando |
| Photocure INC | $27.31 | 2021-2022 | |
| Olympus America INC. | $25.75 | 2025 | Itind System |
| Profound Medical Corp. | $25.68 | 2025 | Tulsa-Pro |
| Acerus Pharmaceuticals Corporation | $24.17 | 2021 | |
| Accord Healthcare, INC. | $21.53 | 2022 | |
| Convatec INC. | $19.28 | 2022 | |
| Allergan, INC. | $16.69 | 2022 | |
| Cook Medical LLC | $11.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collin Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.